Acute Pancreatitis Induced by Polatuzumab-Vedotin-Piiq in Combination With Bendamustine and Rituximab for Diffuse Large B-Cell Lymphomaarticle Published on 2020-09-072024-09-02 Journal: Cureus [Category] 대상포진, [키워드] acute pancreatitis Bendamustine diffuse large B cell lymphoma polatuzumab vedotin-piiq rituximab [DOI] 10.7759/cureus.10299 PMC 바로가기 [Article Type] article
Prolonged Course of COVID-19-Associated Pneumonia in a B-Cell Depleted Patient After RituximabOncology Published on 2020-09-022022-10-31 Journal: Frontiers in Oncology [Category] COVID-19, [키워드] B-cell B-NHL Cancer patients Case report Comorbidity Course COVID-19 Depleted diagnosing diagnostic explain greater help highlight Immunosuppression include Infection initial investigated lymphoma male manifestation monocyte negative test Patient Peripheral blood physician poor prognosis Prolonged risk rituximab SARS-CoV-2 SARS-COV-2 infection shown T cell T-cell activation Treatment [DOI] 10.3389/fonc.2020.01578 PMC 바로가기 [Article Type] Oncology
COVID-19 in 7 multiple sclerosis patients in treatment with ANTI-CD20 therapiesANTI-CD20 요법으로 치료 중인 7명의 다발성 경화증 환자에서 COVID-19Case Reports Published on 2020-09-012022-09-11 Journal: Multiple sclerosis and related disorders [Category] 바이오마커, 진단, [키워드] affected anti-CD20 antibody B cells CD20 Clinical course clinical picture Complication COVID-19 COVID-19 pandemic Diagnosis Evidence Humoral immunity Immunosuppressant immunosuppressants Immunosuppression Infection mAb mAbs material monoclonal antibodies monoclonal antibody Multiple multiple sclerosis Ocrelizumab pandemic Patient patients PCR presence of antibody protective role risk rituximab SARS-CoV-2 SARS-COV-2 infection sclerosis selective serology Seven severity Spread therapy treated Treatment Wuhan [DOI] 10.1016/j.msard.2020.102306 PMC 바로가기 [Article Type] Case Reports
Mild Course of COVID-19 and Spontaneous Virus Clearance in a Patient With Depleted Peripheral Blood B Cells Due to Rituximab Treatment리툭시맙 치료로 인해 말초혈액 B 세포가 고갈된 환자에서 경증의 COVID-19 및 자발적 바이러스 제거Case Reports Published on 2020-09-012022-09-12 Journal: Arthritis & rheumatology (Hoboken, N.J.) [Category] 진단, [키워드] COVID-19 Depleted peripheral rituximab Spontaneous [DOI] 10.1002/art.41380 PMC 바로가기 [Article Type] Case Reports
Evaluation of the immune response to hepatitis B vaccine in patients on biological therapy: results of the RIER cohort studyArticle Published on 2020-09-012023-06-09 Journal: Clinical Rheumatology [Category] B형 간염, [키워드] anti-TNF biological therapy Hepatitis B virus rituximab vaccination [DOI] 10.1007/s10067-020-05042-2
COVID-19 in a Severely Immunosuppressed Patient With Life-Threatening Eosinophilic Granulomatosis With PolyangiitisImmunology Published on 2020-08-282022-11-01 Journal: Frontiers in Immunology [Category] COVID-19, MERS, SARS, [키워드] acute respiratory syndrome Clinical management clinician Complication coronavirus coronavirus disease COVID-19 Cyclophosphamide develop Dyspnea EGPA Eosinophilic eosinophilic granulomatosis with polyangiitis Fever granulomatosis high risk High-dose highly active Immunocompromised patient Immunosuppression immunosuppressive therapy infections life-threatening male Mild moderate pandemic Patient polyangiitis Prednisolone recommendation Rheumatic diseases rituximab SARS-CoV-2 SARS-COV-2 infection severe disease progression Surveillance susceptibility Treatment Vasculitis [DOI] 10.3389/fimmu.2020.02086 PMC 바로가기 [Article Type] Immunology
Management Issues in Myasthenia Gravis Patients Living With HIV: A Case Series and Literature Reviewarticle Published on 2020-08-212024-09-02 Journal: Frontiers in Neurology [Category] 대상포진, [키워드] Autoimmune HIV immune restoration immunosuppressive therapy methotrexate myasthenia gravis rituximab [DOI] 10.3389/fneur.2020.00775 PMC 바로가기 [Article Type] article
COVID‐19 vaccine‐readiness for anti‐CD20‐depleting therapy in autoimmune diseasesArticle Published on 2020-08-012023-06-15 Journal: Clinical and experimental immunology [Category] MERS, SARS, [키워드] Autoimmunity B cell CD20 COVID‐19 Immunotherapy multiple sclerosis Ocrelizumab rheumatoid arthritis rituximab [DOI] 10.1111/cei.13495 PMC 바로가기
Ultra-high sensitivity HBsAg assay can diagnose HBV reactivation following rituximab-based therapy in patients with lymphomaArticle Published on 2020-08-012023-06-13 Journal: Journal of hepatology [Category] B형 간염, [키워드] Anti-CD20 antibody HBV reactivation Preemptive antiviral therapy resolved HBV infection rituximab Ultra-high sensitivity HBsAg assay. [DOI] 10.1016/j.jhep.2020.03.009
Systemic immunosuppression in times of COVID-19: Do we need to rethink our standards?COVID-19 시대의 전신 면역 억제: 우리의 기준을 재고해야 합니까?Review Published on 2020-08-012022-09-11 Journal: Journal der Deutschen Dermatologischen Gesellschaf [Category] 치료제, [키워드] antiviral immunity Autoimmune disease Autoimmune diseases Cardiopulmonary Care Chloroquine Course COVID-19 disease doxycycline doxycycline) Effect effective therapy higher risk Hydroxychloroquine immunoglobulins immunomodulating Immunosuppression immunosuppressive immunosuppressive therapy indication inhibitors intrinsic metabolic conditions Older pandemic Patient pause principle reduction rituximab SARS-CoV-2 SARS-CoV-2 pandemic suppress systemic the SARS-CoV-2 therapy vaccination [DOI] 10.1111/ddg.14194 PMC 바로가기 [Article Type] Review